(Q73167979)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

K R Murry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P S McKinnon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

B Mitrzyk

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M J Rybak

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1252-1260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

In-vitro and in-vivo antimicrobial activities of a novel cephalosporin derivative, CP6162, possessing a dihydroxypyridone moiety at the C-3 side chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Once versus thrice daily gentamicin in patients with serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Early effects of gentamicin, tobramycin, and amikacin on the human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Determinants of efficacy and toxicity of aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1252.30876

10.1592/PHCO.19.16.1252.30876

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555931%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference